Theriva Biologics's total assets for Q1 2025 were $32.16M, a decrease of -9.03% from the previous quarter. TOVX total liabilities were $16.66M for the fiscal quarter, a 2.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.